- Home
- Apac At Home Testing Kits Market
APAC At-Home Testing Kits Market - Industry Trends and Forecast to 2029
- Published Date: September, 2022 | Report ID: CLS-533 | No of pages: 206 | Format:
The Asia-Pacific at-home testing kits market is projected to register a substantial CAGR of 6.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation
The Asia-Pacific At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Others), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, and Online Pharmacies), Country (China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, and Rest of Asia-Pacific) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Asia-Pacific at-home testing kits market are:
Easy availability of self-testing kits at pharmacies
Increase in awareness about the importance of health diagnosis
Market Players
Some of the major players operating in the Asia-Pacific at-home testing kits market are:
Abbott, Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd
Drgerwerk AG & Co. KGaA
Ascensia Diabetes Care Holdings AG
Nectar Lifesciences Ltd.
ACON Laboratories
Quidel Corporation.
ARKRAY USA
BTNX INC.
Atomo Diagnostics
Eurofins Scientific
Piramal Enterprises Ltd.
Bionime Corporation
Nova Biomedical
Cardinal Health
OraSure Technologies
Everlywell
SA Scientific Ltd.
Clearblue
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.3 OVERVIEW OF ASIA PACIFIC AT-HOME TESTING KITS MARKET 33
1.4 LIMITATIONS 35
1.5 MARKETS COVERED 35
2 MARKET SEGMENTATION 38
2.1 MARKETS COVERED 38
2.2 GEOGRAPHICAL SCOPE 39
2.3 YEARS CONSIDERED FOR THE STUDY 40
2.4 CURRENCY AND PRICING 40
2.5 DBMR TRIPOD DATA VALIDATION MODEL 41
2.6 MULTIVARIATE MODELLING 44
2.7 ASIA PACIFIC AT-HOME TESTING KITS MARKET, BY TEST TYPE 44
2.8 MARKET POSITION COVERAGE GRID 45
2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.10 DBMR MARKET POSITION GRID 47
2.11 DISTRIBUTOR CHANNEL ANALYSIS 48
2.12 SECONDARY SOURCES 49
2.13 ASSUMPTIONS 49
3 EXECUTIVE SUMMARY 50
4 PREMIUM INSIGHTS 53
4.1 PESTEL ANALYSIS 55
4.2 PORTER'S FIVE FORCES 56
5 ASIA PACIFIC AT- HOME TESTING KITS MARKET: REGULATIONS 57
5.1 REGULATION IN U.S 57
5.2 GUIDELINES FOR SELF-TESTING KITS 57
5.3 REGULATION IN EUROPE 58
5.4 GUIDELINES FOR TESTING KITS 58
5.5 REGULATION IN INDONESIA: 58
6 MARKET OVERVIEW 60
6.1 DRIVERS 62
6.1.1 GROWING ADOPTION OF SELF-TESTING KITS 62
6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES 62
6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS 62
6.1.4 EASE OF USE AND LOW COSTS OF RAPID SELF-TEST KITS 63
6.2 RESTRAINTS 63
6.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS 63
6.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS 64
6.3 OPPORTUNITIES 65
6.3.1 ADVENT OF ADVANCED TECHNOLOGIES 65
6.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC 65
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS 66
6.4 CHALLENGES 66
6.4.1 HIGH COMPETITION IN THE MEDICAL TECHNOLOGY INDUSTRY 66
6.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS 67
7 ASIA PACIFIC AT-HOME TESTING KITS MARKET, BY TEST TYPE 68
7.1 OVERVIEW 69
7.2 GLUCOSE TESTS 72
7.3 INFECTIOUS DISEASES 72
7.4 PREGNANCY TEST 73
7.5 DRUG ABUSE TEST KITS 74
7.6 HIV TEST KIT 75
7.7 OVULATION PREDICTOR TEST KIT 76
7.8 OTHERS TEST TYPES 76
8 ASIA PACIFIC AT-HOME TESTING KITS MARKET, BY TYPE 78
8.1 OVERVIEW 79
8.2 CASSETTES 82
8.2.1 RETAIL PHARMACIES 83
8.2.2 ONLINE PHARMACIES 83
8.2.3 DRUG STORE 83
8.2.4 SUPERMARKET/HYPERMARKET 83
8.3 STRIP 83
8.3.1 RETAIL PHARMACIES 84
8.3.2 ONLINE PHARMACIES 84
8.3.3 DRUG STORE 84
8.3.4 SUPERMARKET/HYPERMARKET 84
8.4 MIDSTREAM 84
8.4.1 RETAIL PHARMACIES 85
8.4.2 ONLINE PHARMACIES 85
8.4.3 DRUG STORE 85
8.4.4 SUPERMARKET/HYPERMARKET 85
8.5 DIP CARD 86
8.5.1 RETAIL PHARMACIES 86
8.5.2 ONLINE PHARMACIES 87
8.5.3 DRUG STORE 87
8.5.4 SUPERMARKET/HYPERMARKET 87
8.6 TEST PANEL 87
8.6.1 RETAIL PHARMACIES 88
8.6.2 ONLINE PHARMACIES 88
8.6.3 DRUG STORE 88
8.6.4 SUPERMARKET/HYPERMARKET 88
8.7 OTHERS 88
9 ASIA PACIFIC AT-HOME TESTING KITS MARKET, BY AGE 90
9.1 OVERVIEW 91
9.2 ADULT 94
9.3 GERIATRIC 94
9.4 PEDIATRIC 95
10 ASIA PACIFIC AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE 96
10.1 OVERVIEW 97
10.2 BLOOD 100
10.3 URINE 100
10.4 SALIVA 101
10.5 OTHER SAMPLE TYPES 101
11 ASIA PACIFIC AT-HOME TESTING KITS MARKET, BY USAGE 103
11.1 OVERVIEW 104
11.2 DISPOSABLE 107
11.3 REUSABLE 107
12 ASIA PACIFIC AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS 109
12.1 OVERVIEW 110
12.2 RETAIL PHARMACIES 113
12.3 ONLINE PHARMACIES 113
12.4 DRUG STORE 114
12.5 SUPERMARKET/HYPERMARKET 114
13 ASIA PACIFIC AT-HOME TESTING KITS MARKET, BY REGION 116
13.1 ASIA-PACIFIC 117
13.1.1 CHINA 124
13.1.2 JAPAN 127
13.1.3 INDIA 130
13.1.4 SOUTH KOREA 133
13.1.5 AUSTRALIA 136
13.1.6 SINGAPORE 139
13.1.7 INDONESIA 142
13.1.8 THAILAND 145
13.1.9 MALAYSIA 148
13.1.10 PHILIPPINES 151
13.1.11 REST OF ASIA-PACIFIC 154
14 ASIA PACIFIC AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE 155
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 155
15 SWOT ANALYSIS 156
16 COMPANY PROFILE 157
16.1 ABBOTT 157
16.1.1 COMPANY SNAPSHOT 157
16.1.2 REVENUS ANALYSIS 157
16.1.3 COMPANY SHARE ANALYSIS 158
16.1.4 PRODUCT PORTFOLIO 158
16.1.5 RECENT DEVELOPMENT 158
16.2 SIEMENS HEALTHCARE GMBH 159
16.2.1 COMPANY SNAPSHOT 159
16.2.2 REVENUS ANALYSIS 159
16.2.3 PRODUCT PORTFOLIO 160
16.2.4 RECENT DEVELOPMENTS 160
16.3 F. HOFFMANN- LA ROCHE LTD 161
16.3.1 COMPANY SNAPSHOT 161
16.3.2 REVENUE ANALYSIS 161
16.3.3 COMPANY SHARE ANALYSIS 162
16.3.4 PRODUCT PORTFOLIO 162
16.3.5 RECENT DEVELOPMENTS 162
16.4 BD 163
16.4.1 COMPANY SNAPSHOT 163
16.4.2 REVENUE ANALYSIS 163
16.4.3 PRODUCT PORTFOLIO 164
16.4.4 RECENT DEVELOPMENTS 164
16.5 DRGERWERK AG & CO. KGAA 165
16.5.1 COMPANY SNAPSHOT 165
16.5.2 REVENUE ANALYSIS 165
16.5.3 COMPANY SHARE ANALYSIS 166
16.5.4 PRODUCT PORTFOLIO 166
16.5.5 RECENT DEVELOPMENTS 166
16.6 LIFESCAN IP HOLDINGS, LLC 167
16.6.1 COMPANY SNAPSHOT 167
16.6.2 COMPANY SHARE ANALYSIS 167
16.6.3 PRODUCT PORTFOLIO 168
16.6.4 RECENT DEVELOPMENTS 168
16.7 ASCENSIA DIABETES CARE HOLDINGS AG. 169
16.7.1 COMPANY SNAPSHOT 169
16.7.2 COMPANY SHARE ANALYSIS 169
16.7.3 PRODUCT PORTFOLIO 170
16.7.4 RECENT DEVELOPMENTS 170
16.8 NECTAR LIFESCIENCES LTD. (RAPIKIT) 171
16.8.1 COMPANY SNAPSHOT 171
16.8.2 PRODUCT PORTFOLIO 171
16.8.3 RECENT DEVELOPMENTS 171
16.9 ACON LABORATORIES, INC. 172
16.9.1 COMPANY SNAPSHOT 172
16.9.2 PRODUCT PORTFOLIO 172
16.9.3 RECENT DEVELOPMENTS 172
16.10 QUIDEL CORPORATION. 173
16.10.1 COMPANY SNAPSHOT 173
16.10.2 REVENUE ANALYSIS 173
16.10.3 PRODUCT PORTFOLIO 174
16.10.4 RECENT DEVELOPMENTS 174
16.11 ARKRAY USA, INC. 175
16.11.1 COMPANY SNAPSHOT 175
16.11.2 PRODUCT PORTFOLIO 175
16.11.3 RECENT DEVELOPMENTS 175
16.12 BTNX INC. 176
16.12.1 COMPANY SNAPSHOT 176
16.12.2 PRODUCT PORTFOLIO 176
16.12.3 RECENT DEVELOPMENTS 176
16.13 ATOMO DIAGNOSTICS 177
16.13.1 COMPANY SNAPSHOT 177
16.13.2 REVENUE ANALYSIS 177
16.13.3 PRODUCT PORTFOLIO 178
16.13.4 RECENT DEVELOPMENTS 178
16.14 EUROFINS SCIENTIFIC 179
16.14.1 COMPANY SNAPSHOT 179
16.14.2 REVENUE ANALYSIS 179
16.14.3 PRODUCT PORTFOLIO 180
16.14.4 RECENT DEVELOPMENTS 180
16.15 PIRAMAL ENTERPRISES LTD. 181
16.15.1 COMPANY SNAPSHOT 181
16.15.2 REVENUE ANALYSIS 181
16.15.3 PRODUCT PORTFOLIO 182
16.15.4 RECENT DEVELOPMENTS 182
16.16 BIONIME CORPORATION 183
16.16.1 COMPANY SNAPSHOT 183
16.16.2 REVENUE ANALYSIS 183
16.16.3 PRODUCT PORTFOLIO 184
16.16.4 RECENT DEVELOPMENTS 184
16.17 NOVA BIOMEDICAL 185
16.17.1 COMPANY SNAPSHOT 185
16.17.2 PRODUCT PORTFOLIO 185
16.17.3 RECENT DEVELOPMENTS 185
16.18 CARDINAL HEALTH. 186
16.18.1 COMPANY SNAPSHOT 186
16.18.2 REVENUE ANALYSIS 186
16.18.3 PRODUCT PORTFOLIO 187
16.18.4 RECENT DEVELOPMENTS 187
16.19 ORASURE TECHNOLOGIES 188
16.19.1 COMPANY SNAPSHOT 188
16.19.2 REVENUE ANALYSIS 188
16.19.3 PRODUCT PORTFOLIO 189
16.19.4 RECENT DEVELOPMENTS 189
16.20 BIOLYTICAL LABORATORIES INC. 190
16.20.1 COMPANY SNAPSHOT 190
16.20.2 PRODUCT PORTFOLIO 190
16.20.3 RECENT DEVELOPMENTS 190
16.21 EVERLYWELL, INC. 191
16.21.1 COMPANY SNAPSHOT 191
16.21.2 PRODUCT PORTFOLIO 191
16.21.3 RECENT DEVELOPMENTS 191
16.22 SA SCIENTIFIC LTD. 192
16.22.1 COMPANY SNAPSHOT 192
16.22.2 PRODUCT PORTFOLIO 192
16.22.3 RECENT DEVELOPMENTS 192
16.23 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH) 193
16.23.1 COMPANY SNAPSHOT 193
16.23.2 PRODUCT PORTFOLIO 193
16.23.3 RECENT DEVELOPMENTS 193
16.24 BIOSYNEX 194
16.24.1 COMPANY SNAPSHOT 194
16.24.2 PRODUCT PORTFOLIO 194
16.24.3 RECENT DEVELOPMENTS 194
16.25 PRIMA LAB SA 195
16.25.1 COMPANY SNAPSHOT 195
16.25.2 PRODUCT PORTFOLIO 195
16.25.3 RECENT DEVELOPMENTS 196
16.26 MP BIOMEDICALS. 197
16.26.1 COMPANY SNAPSHOT 197
16.26.2 PRODUCT PORTFOLIO 197
16.26.3 RECENT DEVELOPMENTS 197
16.27 STERILAB SERVICES 198
16.27.1 COMPANY SNAPSHOT 198
16.27.2 PRODUCT PORTFOLIO 198
16.27.3 RECENT DEVELOPMENTS 198
16.28 CHEMBIO DIAGNOSTICS, INC. 199
16.28.1 COMPANY SNAPSHOT 199
16.28.2 REVENUE ANALYSIS 199
16.28.3 PRODUCT PORTFOLIO 200
16.28.4 RECENT DEVELOPMENTS 200
16.29 BIOSURE 201
16.29.1 COMPANY SNAPSHOT 201
16.29.2 PRODUCT PORTFOLIO 201
16.29.3 RECENT DEVELOPMENTS 201
16.30 SELFDIAGNOSTICS OU 202
16.30.1 COMPANY SNAPSHOT 202
16.30.2 PRODUCT PORTFOLIO 202
16.30.3 RECENT DEVELOPMENTS 202
17 QUESTIONNAIRE 203
18 RELATED REPORTS 206
Segmentation
Short Description
Asia-Pacific At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Others), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, and Online Pharmacies), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Rest of Middle East and Africa, Brazil, Argentina, Caribbean, Colombia, Peru, Chile, Panama, Venezuela, and Rest of South America) Industry Trends and Forecast to 2029
Market Definition
At-home testing kits means testing instruments which help people to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person. Their processes, packaging and instructions have been simplified so as to guide person through the steps of taking a test. Various at-home test kits are available including HIV test, pregnancy test, diabetes test, ovulation test, test for infectious diseases such as malaria, COVID-19, and others. For performing these rapid at-home tests, blood, urine, and oral fluid can be taken as a sample.
Market Segmentation
The Asia-Pacific at-home testing kits market is categorized into six segments: test type, type, age, sample type, usage, and distribution channels.
On the basis of test type, the Asia-Pacific at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit, and others
On the basis of type, the Asia-Pacific at-home testing kits market is segmented into cassette, strip, midstream, test panel, dip card, and others
On the basis of age, the Asia-Pacific at-home testing kits market is segmented into pediatric, adult, and geriatric
On the basis of sample type, the Asia-Pacific at-home testing kits market is segmented into urine, blood, saliva, and others
On the basis of usage, the Asia-Pacific at-home testing kits market is segmented into disposable and reusable
On the basis of distribution channels, the Asia-Pacific at-home testing kits market is segmented into retail pharmacies, drug store, supermarket/hypermarket, and online pharmacies
Market Players
The major companies which are dealing in the Asia-Pacific at-home testing kits market are listed below:
Abbott, Siemens Healthcare GmbH
F. Hoffmann La-Roche Ltd
Drgerwerk AG & Co. KGaA
LifeScan IP Holdings
Ascensia Diabetes Care Holdings AG
Nectar Lifesciences Ltd. (Rapikit)
ACON Laboratories, Inc.
Quidel Corporation.
ARKRAY USA, Inc.
BTNX INC.
Atomo Diagnostics
Eurofins Scientific
Piramal Enterprises Ltd.
Bionime Corporation
Nova Biomedical
Cardinal Health
OraSure Technologies, Inc.
BioLytical Laboratories Inc.
Everlywell, Inc.
SA Scientific Ltd.
Clearblue
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.